Evidence map›Paper›PMID 24751526›Full record

ReviewFree radical biology & medicine2014

Circulating membrane-derived microvesicles in redox biology.

Michael Craig Larson, Cheryl A Hillery, Neil Hogg

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Free radical biology & medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02940327 (A Feasibility Study to Consider the Relationship Between Markers of Red Cell Damage, Inflammation and the Recovery Process of Newborns Requiring Extracorporeal Membrane Oxygenation), which is not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02940327 completednot on this mapstarted 2016, after this paper: background citation

A Feasibility Study to Consider the Relationship Between Markers of Red Cell Damage, Inflammation and the Recovery Process of Newborns Requiring Extracorporeal Membrane Oxygenation (ECMO) for Persistent Pulmonary Hypertension of the Newborn (PPHN): Mi-ECMO

TypeobservationalSponsorUniversity of LeicesterRan2016 to 2017Enrolled24ConditionsPersistent Pulmonary Hypertension of the Newborn
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Exosome: A New Player in Translational Nanomedicine.Journal of clinical medicine · 2020
    Review
  10. Article
  11. Article
  12. Label-free visualization and characterization of extracellular vesicles in breast cancer.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  13. Microvesicles: ROS scavengers and ROS producers.Journal of extracellular vesicles · 2019
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Extracellular Vesicles in Angiogenesis.Circulation research · 2017
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Michael Craig LarsonDepartment of Biophysics and Medical College of Wisconsin, Milwaukee, WI 53226, USA; Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI 53226, USA.
Cheryl A HilleryBlood Research Institute, BloodCenter of Wisconsin, Milwaukee, WI 53226, USA; Department of Pediatrics and Children's Research Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Neil HoggDepartment of Biophysics and Medical College of Wisconsin, Milwaukee, WI 53226, USA. Electronic address: nhogg@mcw.edu.
Versiti Blood Center of Wisconsin · USMedical College of Wisconsin · US

Funding

Nociceptive Mechanisms Underlying Sickle Cell PainR01NS070711 · NINDS · MEDICAL COLLEGE OF WISCONSIN · PI Bonnie N Dittel, Cheryl Louise Stucky · 2009 to 2026
$8.7M
Medical Scientist Training ProgramT32GM080202 · NIGMS · MEDICAL COLLEGE OF WISCONSIN · PI BARBIERI, JOSEPH T, SALZMAN, NITA H · 2010 to 2024
$5.7M
Sickle Cell ScholarU54HL090503 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI PANEPINTO, JULIE A · 2008 to 2011
$3.0M
NHLBI NIH HHS U54 HL090503NHLBI NIH HHS U54HL090503NIGMS NIH HHS GM080202NIGMS NIH HHS T32 GM080202NINDS NIH HHS R01 NS070711NINDS NIH HHS R01NS070711PHS HHS R01NL102836
6 · The paper itself

Abstract

Microparticles or microvesicles (MVs) are subcellular membrane blebs shed from all cells in response to various stimuli. MVs carry a battery of signaling molecules, many of them related to redox-regulated processes. The role of MVs, either as a cause or as a result of cellular redox signaling, has been increasingly recognized over the past decade. This is in part due to advances in flow cytometry and its detection of MVs. Notably, recent studies have shown that circulating MVs from platelets and endothelial cells drive reactive species-dependent angiogenesis; circulating MVs in cancer alter the microenvironment and enhance invasion through horizontal transfer of mutated proteins and nucleic acids and harbor redox-regulated matrix metalloproteinases and procoagulative surface molecules; and circulating MVs from red blood cells and other cells modulate cell-cell interactions through scavenging or production of nitric oxide and other free radicals. Although our recognition of MVs in redox-related processes is growing, especially in the vascular biology field, much remains unknown regarding the various biologic and pathologic functions of MVs. Like reactive oxygen and nitrogen species, MVs were originally believed to have a solely pathological role in biology. And like our understanding of reactive species, it is now clear that MVs also play an important role in normal growth, development, and homeostasis. We are just beginning to understand how MVs are involved in various biological processes-developmental, homeostatic, and pathological-and the role of MVs in redox signaling is a rich and exciting area of investigation.

Indexed as

AnimalsBlood PlateletsCell-Derived MicroparticlesCell MembraneEndothelial CellsHumansLymphocytesMacrophagesMatrix MetalloproteinasesMuscle, Smooth, VascularNeoplasmsNeovascularization, PathologicNeutrophilsOxidation-ReductionOxidative StressMatrix MetalloproteinasesFree radicalsMicroparticlesMicrovesiclesPathologyPhospholipidsRedox signaling

Identifiers

PMID24751526
PMCPMC4465756
OpenAlexW1999051238

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.